Google Übersetzer
Modus Therapeutics Holding Ab
About
Modus Therapeutics Holding Ab — investor relations, events, news, and company updates on 6ix.
Latest News
Nov 14 2025
Interim Report - January-September 2025
Nov 4 2025
Karolinska Development's portfolio company Modus Therapeutics receives approval for second part of phase 2 study in chronic kidney disease with anemia
Sep 18 2025
Neumirna Therapeutics Appoints Ellen K. Donnelly as Chief Executive Officer
Aug 28 2025
Karolinska Development's portfolio company Modus Therapeutics raises SEK 28.3 million in oversubscribed unit issue
Jul 14 2025
Karolinska Development's portfolio company Modus Therapeutics completes enrollment in part 1 of its phase 2a study with sevuparin